Skip to main content

Search Results

Suggested Reading - Childhood Leukemia Guide for Families, Friends and Caregivers, 5th ed.

By Nancy Keene
Childhood Cancer Guides, 2018, 496 pages
ISBN: 978-1-941089-04-0

This most complete parent guide provides accurate and understandable medical information about leukemia and the various treatment options, as well as day-to-day practical advice on how to cope with procedures, hospitalization, family and friends, school, social and financial issues, and communicating with healthcare providers. Reviewed by distinguished experts in pediatric oncology, Childhood Leukemia includes practical and poignant stories from more than 175 parents, children with leukemia, and their siblings. This book helps families cope––one day at a time.

For more information click here

Childhood Leukemia
Audience
Adults
Subject
Coping

#ASH16 (Blog 2): Innovations in AML and Surprising Results for CML

This is the second of a series of blogs covering the 58th ASH Annual Meeting and Exposition in San Diego (#ASH16) conference over the next few days. Check back for more news from the meeting.

Because of You, We're Helping to Cure Cancer

Here at The Leukemia & Lymphoma Society (LLS), we remain laser-focused on continuing to drive forward our mission. In fact, we are amplifying our efforts to help patients and caregivers access the care they need, during the coronavirus crisis and beyond. Thankfully, we have a vibrant community of dedicated volunteers across the country who are just as relentless as we are about making a difference in the lives of blood cancer patients and their families. 

Filgrastim-sndz

Filgrastim-sndz is FDA approved as a biosimilar to US-licensed Neupogen® for the five indications for which Neupogen is approved:

  • Patients with cancer receiving myelosuppressive chemotherapy;
  • Patients with acute myeloid leukemia receiving induction or consolidation chemotherapy;
  • Patients with cancer undergoing bone marrow transplantation;
  • Patients undergoing autologous peripheral blood progenitor cell collection and therapy; and
  • Patients with severe chronic neutropenia.

Interferon alfa-2b

Interferons are substances naturally produced by cells in the body to help fight infections and tumors. They may also be synthetic versions of these substances.

Interferon alfa-2b is FDA approved to treat people who have hairy cell leukemia, polycythemia vera and aggressive follicular non-Hodgkin lymphoma.